Ischemic Post-conditioning in the Treatment of Acute Ischemic Stroke--a Multicenter, Prospective Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

Post-ischemic adaptation is a physical brain protective treatment strategy in which an ischemic event in an organ or tissue is treated and blood flow is restored, and an ischemic stimulus is given to local tissues to induce the production of anti-ischemic damage factors and reduce the damage associated with reperfusion therapy . Relevant basic studies have confirmed that post-ischemic adaptation can reduce infarct volume and promote neurological function recovery in animal models of cerebral infarction. Therefore, it may be beneficial to the recovery of neurological function in patients with acute ischemic stroke undergoing mechanical thrombus extraction. Based on the above background, the use of a balloon to repeatedly dilate-contract at the original occlusion site after revascularization to block and restore arterial flow may be an effective cerebroprotective treatment for patients with large-vessel occlusion who undergo thrombolysis. However, can this approach be safely used in patients with acute ischemic stroke treated with thrombolysis? What is the protocol for the length of time patients can tolerate post-ischemic adaptation? The application of this method in the treatment of acute ischemic stroke will be explored in this study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 1)Ischemic stroke confirmed by CT or MRI of the head;

• 2\) Large vessel occlusion confirmed by CTA or MRA of the head, including: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2);

• 3\) Recanalization of the occluded vessel at eTICI grade 2b/3 as confirmed by DSA after thrombectomy;

• 4)The patient/legally authorized representative has signed an informed consent form.

Locations
Other Locations
China
Tianjin Huanhu Hospital
RECRUITING
Tianjin
Contact Information
Primary
Ming Wei, PhD
drweiming@163.com
13502182903
Time Frame
Start Date: 2021-11-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 200
Treatments
Post-ischemic adaptation to combined endovascular therapy
Endovascular therapy alone
Related Therapeutic Areas
Sponsors
Leads: Ming Wei

This content was sourced from clinicaltrials.gov

Similar Clinical Trials